CRISPR Therapeutics AG (CRSP) Presents at Goldman Sachs 42nd Annual Global Healthcare Broker Conference Call - (Transcript)

CRISPR Therapeutics AG (NASDAQ:CRSP) Goldman Sachs 42nd Annual Global Healthcare Conference June 8, 2021 3:00 PM ET Company Participants Samarth Kulkarni - CEO & Director Conference Call Participants Salveen Richter - Goldman Sachs Group Salveen Richter With that, Sam, thanks for joining us. And to start here, maybe just to kind of level set everyone on the business, what do you think of your various modalities, I would say, of in vivo gene editing, ex vivo gene editing, the allogeneic oncology platform and ...